High-sensitivity cardiac troponin assays and unstable angina

European Heart Journal: Acute Cardiovascular Care

Volumn 7, Issue 2, 2018, Pages 120-128

  Sandoval, Yader ^a,b   Apple, Fred S ^c   Smith, Stephen W ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

acute coronary syndrome; cardiac troponin; high sensitivity cardiac troponin; myocardial infarction; Unstable angina

Indexed keywords

TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIAC TROPONIN ASSAY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY ASSESSMENT; HEART MUSCLE INJURY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SENSITIVITY ANALYSIS; UNSTABLE ANGINA PECTORIS; BLOOD; REPRODUCIBILITY;

ANGINA, UNSTABLE; BIOMARKERS; HUMANS; REPRODUCIBILITY OF RESULTS; TROPONIN I; TROPONIN T;

EID: 85044629353     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872616658591     Document Type: Review

References (53)

1. Braunwald E, Jones RH, Mark DB. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994; 90: 613–622.
2. Gazed PC, Mobley EM, Jr Faris HM, Jr. Preinfarctional (unstable) angina – A prospective study – Ten year follow up. Prognostic significant of electrocardiographic changes. Circulation 1973; 48: 331–337.
3. Fowler NO. “Preinfarctional” angina. A need for an objective definition and for a controlled clinical trial of its management. Circulation 1971; 44: 755–758.
4. Ambrose JA, Dangas G. Unstable angina: Current concepts of pathogenesis and treatment. Arch Intern Med 2000; 160: 25–37.
5. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410–414.
6. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102: 118–122.
7. Chahine RA. Unstable angina. The problem of definition. Br Heart J 1975; 37: 1246–1249.
8. Ladenson JH. Reflections on the evolutions of cardiac biomarkers. Clin Chem 2012; 58: 21–24.
9. Braunwald E, Califf RM, Cannon CP. Redefining medical treatment in the management of unstable angina. Am J Med 2000; 108: 41–53.
10. Hamm CW, Ravkilde J, Gerhardt W. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146–150.
11. Hamm CW, Heeschen C, Goldmann B. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340: 1623–1629.
12. Morrow DA, Antman EM, Tanasijevic M. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI-11B substudy. J Am Coll Cardiol 2000; 36: 1812–1817.
13. Morrow DA, Cannon CP, Rifai N.; TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial. JAMA 2001; 286: 2405–2412.
14. Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol 2013; 61: 1753–1758.
15. Apple FS, Jaffe AS, Collinson P.; International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015; 48: 201–203.
16. Apple FS, Collinson PO, ; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54–61.
17. Amsterdam EA, Wenger NK, Brindis RG.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association for Clinical Chemistry. 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64: e139–e228.
18. Roffi M, Patrono C, Collet JP. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267–315.
19. Mendis S, Thygesen K, Kuulasmaa K.; Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization definition of myocardial infarction: 2008–2009 revision. Int J Epidemiol 2011; 40: 139–146.
20. Braunwald E, Antman EM, Beasley JW. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970–1062.
21. Thygesen K, Alpert JS, Jaffe AS.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons; Biomarker Subcommittee; ECG Subcommittee; Imaging Subcommittee; Classification Subcommittee; Intervention Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581–1598.
22. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values form a common presumably healthy population. Clin Chem 2012; 58: 1574–1581.
23. Sandoval Y, Smith SW, Apple FS. Present and future of cardiac troponin in clinical practice: A paradigm shift to high sensitivity assays. Am J Med 2016; 129: 354–365.
24. Thom T, Haase N, Rosamond W.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–e151.
25. Rosamond W, Flegal K, Friday G.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69–e171.
26. Rosamond W, Flegal K, Furie K.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25–e146.
27. Lloyd-Jones D, Adams R, Carnethon M.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21–e181.
28. Lloyd-Jones D, Adams RJ, Brown TM.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2010 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2010; 121: e46–e215.
29. Roger VL, Go AS, Lloyd-Jones DM.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2011 update: A report from the American Heart Association. Circulation 2011; 123: e18–e209.
30. Roger VL, Go AS, Lloyd-Jones DM.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2012 update: A report from the American Heart Association. Circulation 2012; 125: e2–e220.
31. Go AS, Mozaffarian D, Roger VL.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2013 update: A report from the American Heart Association. Circulation 2013; 127: e6–e245.
32. Go AS, Mozaffarian D, Roger VL.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2014 update: A report from the American Heart Association. Circulation 2014; 129: e28–e292.
33. Mozaffarian D, Benjamin EJ, Go AS.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation 2015; 131: e29–e322.
34. Mozaffarian D, Benjamin EJ, Go AS.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2016 update: A report from the American Heart Association. Circulation 2016; 133: e38–e360.
35. Luepker RV, Apple FS, Christenson RH.; AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108: 2543–2549.
36. D’Souza M, Sarkisian L, Saaby L. Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays. Am J Med 2015; 128: 852–860.
37. Braunwald E, Morrow DA. Unstable angina: Is it time for a requiem? Circulation 2013; 127: 2452–2457.
38. Reichlin T, Twerenbold R, Reiter M. Introduction of high-sensitivity troponin assays: Impact on myocardial infarction incidence and prognosis. Am J Med 2012; 125: 1205–1213.
39. Love SA, Sandoval Y, Smith SW. Incidence of undetectable, measurable, and increased cardiac troponin I concentrations above the 99th percentile using a high-sensitivity versus a contemporary assay in patients presenting to the emergency department. Clin Chem. Epub ahead of print 2016. DOI: 10.1373/clinchem.2016.256305.
40. Latini R, Masson S, Anand IS.; Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007; 116: 1242–1249.
41. Masson S, Anand I, Favero C.; Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: Data from 2 large randomized clinical trials. Circulation 2012; 125: 280–288.
42. Jhund PS, Claggett BL, Voors AA.; PARAMOUNT Investigators. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail 2014; 7: 953–959.
43. Apple FS. Counterpoint: Standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem 2012; 58(1): 169–171.
44. Apple FS, Jaffe AS. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: User beware. Clin Chem 2012; 58(11): 1599–1600.
45. Chin CW, Shah AS, McAllister DA. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J 2014; 35: 2312–2321.
46. deFilippi C, Seliger SL, Kelley W. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem 2012; 58: 1342–1351.
47. Fahim MA, Hayen AD, Horvath AR. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: Implications for clinical practice. Clin Chem Lab Med 2015; 53: 715–722.
48. Apple FS, Ler R, Love SA. High sensitivity cardiac troponin I and T assays for predicting death in hemodialysis population. Clin Chem 2015; 61(10): Abstract B-016.
49. Sandoval Y, Herzog CA, Love SA. Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients. Clin Chem 2016; 62: 631–638.
50. Shah AS, Anand A, Sandoval Y.; High-STEACS Investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: A cohort study. Lancet 2015; 386: 2481–2488.
51. Body R, Carley S, McDowell G. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011; 58: 1332–1339.
52. Thelin J, Melander O, Ohlin B. Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T. Eur Heart J Acute Cardiovasc Care 2015; 4: 403–409.
53. Bjurman C, Larsson M, Johanson P. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 2013; 62: 1231–1238.